- Home
- News and Events
This section of the website contains the European Medicines Agency's news and press releases, information on meetings and events, public consultations and related information.
For a scrolling feed of all of the new and updated information published on the website, see the what's new page.
Latest news
-
2018-07-20 : CVMP
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 17–19 July 2018
-
2018-07-18 : EMA
EU and Japan reinforce their collaboration on inspections of medicine manufacturers
-
2018-07-17 : EMA
Update on review of valsartan medicines following detection of impurity in active substance
-
2018-07-16 : EMA
-
2018-07-13 : PRAC
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9-12 July 2018
-
2018-07-11 : EMA
EMA’s Pharmacovigilance and Risk Assessment Committee (PRAC) elects new Chair
-
2018-07-10 : EMA
-
2018-07-05 : EMA
EMA reviewing medicines containing valsartan from Zhejiang Huahai following detection of an impurity
-
2018-06-29 : CHMP
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 June 2018
-
2018-06-29 : CHMP
First two CAR-T cell medicines recommended for approval in the European Union
-
2018-06-29 : CMDh
Hydroxyethyl starch solutions: CMDh introduces new measures to protect patients
-
2018-06-22 : CVMP
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 19–21 June 2018
-
2018-06-22 : EMA
-
2018-06-22 : CVMP
First stem cell-based veterinary medicine recommended for marketing authorisation
-
2018-06-21 : CAT
-
2018-06-19 : EMA
-
2018-06-19 : EMA
Guidance for pharmaceutical companies to prepare for UK’s withdrawal from EU
-
2018-06-15 : PRAC
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 11-14 June 2018
-
2018-06-14 : EMA
-
2018-06-07 : EMA
This month's events
-
2018-01-17 - 2018-01-19 : CAT
Committee for Advanced Therapies (CAT): 17-19 January 2018
The Committee for Advanced Therapies (CAT) is the committee that is responsible for assessing the quality, safety and efficacy of advanced-therapy medicines.
Latest patient safety information
-
2018-07-17
Update on review of valsartan medicines following detection of impurity in active substance
-
2018-07-05
EMA reviewing medicines containing valsartan from Zhejiang Huahai following detection of an impurity
-
2018-06-29
Hydroxyethyl starch solutions: CMDh introduces new measures to protect patients
-
2018-06-01
Esmya: new measures to minimise risk of rare but serious liver injury
-
2018-05-18
EMA review of Zinbryta confirms medicine’s risks outweigh its benefits
RSS feed
Twitter
YouTube
